HopeStage
Back to all studies
CompletedNCT00581009

Sleep deprivation and sertraline treatment for depression

About this titleRead the official source — NCT00581009
Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
Irvine and 1 more locationSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 30, 2001
Recruitment status
Completed
Enrollment listed in the registry
49
Sponsor
University of California, Irvine
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other, Radiation
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00581009
Official title
Show the full official title

The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Irvine · La Jolla

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Irvine, a university.

Did this study involve medication?

Yes. The study involved medication, including sertraline, lithium.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies